Lumiera Health Inc. (TSXV: NHP.H)
Health Care · Pharmaceuticals · CA
CA$—
— today · — 1Y
Lumiera Health Inc. (TSXV: NHP.H) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $621.96K.
trading between 0.01 and 0.01.
Tweenvest scores Lumiera Health Inc. across four factors: quality 7/100, growth 71/100. Its strongest factor is growth.
NHP.H price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $621.96K
- Revenue (TTM)
- $320.08K
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -0.27
- 52-week high
- CA$0.01
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 169.97M
- Employees
- —
- Next earnings
- —
About Lumiera Health Inc.
Lumiera Health Inc., together with its subsidiaries, develops and commercializes evidence-based botanical products for the healthcare in Canada. It sells oral and topical botanical agents to manage unmet medical needs; and solutions for sleep-aids and pain management. The company offers herbal tonics and supplements for cardiovascular health, stress relief, bones, joints and muscle mobility, and energy and immunity under the Holizen brand; sleep aid products under the Bazzzics brand; and pain relief cream under the Awaye brand. Lumiera Health Inc. is headquartered in Saint-Hubert, Canada.
- ISIN
- CA5502541066
- Listed since
- Nov 20, 2013
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.